This study investigates advanced solid tumors. It will look at how participants with this condition respond to a new investigational medication.
The study evaluates the safety and tolerability of the medication. Researchers will also observe its effects and how participants' bodies handle the medication.
- Who can participate: Participants must be 18 years or older with advanced solid tumors. They should have specific gene mutations and meet certain health criteria.
- Study details: Participants will take the investigational medication.
How understandable was the trial content above?
Hard to understand
Easy to understand